Arsenite-induced pseudo-hypoxia results in loss of anchorage-dependent growth in BEAS-2B pulmonary epithelial cells

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Zhao, Fei ^a   Malm, Scott W ^a   Hinchman, Alyssa N ^a   Li, Hui ^a   Beeks, Connor G ^a   Klimecki, Walter T ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC TRIOXIDE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; ARSENOUS ACID DERIVATIVE; HIF1A PROTEIN, HUMAN; LACTIC ACID; OLIGONUCLEOTIDE;

AMINO ACID SYNTHESIS; ANCHORAGE DEPENDENT GROWTH; ARTICLE; BINDING AFFINITY; CELL FRACTIONATION; CELL GROWTH; COLONY FORMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENVIRONMENTAL EXPOSURE; EPITHELIUM CELL; GLYCOLYSIS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LUNG ALVEOLUS EPITHELIUM; OXIDATIVE PHOSPHORYLATION; PHENOTYPE; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; RNA ISOLATION; ANALYSIS OF VARIANCE; CELL HYPOXIA; CELL LINE; DRUG EFFECTS; ENERGY METABOLISM; FLUORESCENT ANTIBODY TECHNIQUE; HALF LIFE TIME; LUNG ALVEOLUS CELL; MASS FRAGMENTOGRAPHY; METABOLISM; METABOLOMICS; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION;

ANALYSIS OF VARIANCE; ARSENITES; CELL HYPOXIA; CELL LINE; ENERGY METABOLISM; FLUORESCENT ANTIBODY TECHNIQUE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GLYCOLYSIS; HALF-LIFE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOBLOTTING; LACTIC ACID; METABOLOMICS; OLIGONUCLEOTIDES; PNEUMOCYTES; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84918556503     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0114549     Document Type: Article

References (41)

1. Smith AH, Goycolea M, Haque R, Biggs ML (1998) Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water. American journal of epidemiology 147: 660-669.
2. Smith AH, Hopenhayn-Rich C, Bates MN, Goeden HM, Hertz-Picciotto I, et al. (1992) Cancer risks from arsenic in drinking water. Environmental health perspectives 97: 259-267.
3. Smith AH, Lingas EO, Rahman M (2000) Contamination of drinking-water by arsenic in Bangladesh: a public health emergency. Bulletin of the World Health Organization 78: 1093-1103.
4. Guo HR, Wang NS, Hu H, Monson RR (2004) Cell type specificity of lung cancer associated with arsenic ingestion. Cancer Epidemiol Biomarkers Prev 13: 638-643.
5. Zhao F, Severson P, Pacheco S, Futscher BW, Klimecki WT (2013) Arsenic exposure induces the Warburg effect in cultured human cells. Toxicology and applied pharmacology 271: 72-77.
6. Mazurek S, Eigenbrodt E, Failing K, Steinberg P (1999) Alterations in the glycolytic and glutaminolytic pathways after malignant transformation of rat liver oval cells. J Cell Physiol 181: 136-146.
7. Hume DA, Radik JL, Ferber E, Weidemann MJ (1978) Aerobic glycolysis and lymphocyte transformation. Biochem J 174: 703-709.
8. Hu Y, Lu W, Chen G, Wang P, Chen Z, et al. (2012) K-ras(G12V) transformation leads to mitochondrial dysfunction and a metabolic switch from oxidative phosphorylation to glycolysis. Cell Res 22: 399-412.
9. Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324: 1029-1033.
10. Koppenol WH, Bounds PL, Dang CV (2011) Otto Warburg's contributions to current concepts of cancer metabolism. Nat Rev Cancer 11: 325-337.
11. Moran LA (2012) Principles of biochemistry. Boston: Pearson. xxxiii, 786 p. p.
12. Pizer LI (1963) The Pathway and Control of Serine Biosynthesis in Escherichia Coli. J Biol Chem 238: 3934-3944.
13. Semenza GL, Roth PH, Fang HM, Wang GL (1994) Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. The Journal of biological chemistry 269: 23757-23763.
14. Gordan JD, Simon MC (2007) Hypoxia-inducible factors: central regulators of the tumor phenotype. Curr Opin Genet Dev 17: 71-77.
15. Hewitson KS, McNeill LA, Riordan MV, Tian YM, Bullock AN, et al. (2002) Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family. J Biol Chem 277: 26351-26355.
16. McNeill LA, Hewitson KS, Gleadle JM, Horsfall LE, Oldham NJ, et al. (2002) The use of dioxygen by HIF prolyl hydroxylase (PHD1). Bioorg Med Chem Lett 12: 1547-1550.
17. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, et al. (1999) The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399: 271-275.
18. Li Q, Chen H, Huang X, Costa M (2006) Effects of 12 metal ions on iron regulatory protein 1 (IRP-1) and hypoxia-inducible factor-1 alpha (HIF-1alpha) and HIF-regulated genes. Toxicology and applied pharmacology 213: 245-255.
19. Ke Q, Costa M (2006) Hypoxia-inducible factor-1 (HIF-1). Molecular pharmacology 70: 1469-1480.
20. Johnen G, Rozynek P, von der Gathen Y, Bryk O, Zdrenka R, et al. (2013) Cross-contamination of a UROtsa stock with T24 cells-molecular comparison of different cell lines and stocks. PLoS One 8: e64139.
21. Hou Y, Xue P, Woods CG, Wang X, Fu J, et al. (2013) Association between arsenic suppression of adipogenesis and induction of CHOP10 via the endoplasmic reticulum stress response. Environ Health Perspect 121: 237-243.
22. Stueckle TA, Lu Y, Davis ME, Wang L, Jiang BH, et al. (2012) Chronic occupational exposure to arsenic induces carcinogenic gene signaling networks and neoplastic transformation in human lung epithelial cells. Toxicology and applied pharmacology 261: 204-216.
23. Liu LZ, Jiang Y, Carpenter RL, Jing Y, Peiper SC, et al. (2011) Role and mechanism of arsenic in regulating angiogenesis. PLoS One 6: e20858.
24. Amstad P, Reddel RR, Pfeifer A, Malan-Shibley L, Mark GE, 3rd, et al. (1988) Neoplastic transformation of a human bronchial epithelial cell line by a recombinant retrovirus encoding viral Harvey ras. Mol Carcinog 1: 151-160.
25. Zhao F, Wu T, Lau A, Jiang T, Huang Z, et al. (2009) Nrf2 promotes neuronal cell differentiation. Free Radic Biol Med 47: 867-879.
26. A J, Trygg J, Gullberg J, Johansson AI, Jonsson P, et al. (2005) Extraction and GC/MS analysis of the human blood plasma metabolome. Anal Chem 77: 8086-8094.
27. Bolt AM, Douglas RM, Klimecki WT (2010) Arsenite exposure in human lymphoblastoid cell lines induces autophagy and coordinated induction of lysosomal genes. Toxicology letters 199: 153-159.
28. de Oliveira Ribeiro CA, Nathalie MD, Gonzalez P, Yannick D, Jean-Paul B, et al. (2008) Effects of dietary methylmercury on zebrafish skeletal muscle fibres. Environ Toxicol Pharmacol 25: 304-309.
29. Zhang T, Qi Y, Liao M, Xu M, Bower KA, et al. (2012) Autophagy is a cell self-protective mechanism against arsenic-induced cell transformation. Toxicological sciences: an official journal of the Society of Toxicology 130: 298-308.
30. Carpenter RL, Jiang Y, Jing Y, He J, Rojanasakul Y, et al. (2011) Arsenite induces cell transformation by reactive oxygen species, AKT, ERK1/2, and p70S6K1. Biochem Biophys Res Commun 414: 533-538.
31. Xu Y, Zhao Y, Xu W, Luo F, Wang B, et al. (2013) Involvement of HIF-2alpha-mediated inflammation in arsenite-induced transformation of human bronchial epithelial cells. Toxicol Appl Pharmacol 272: 542-550.
32. Li G, Lee LS, Li M, Tsao SW, Chiu JF (2011) Molecular changes during arsenic-induced cell transformation. J Cell Physiol 226: 3225-3232.
33. He Q, Gao Z, Yin J, Zhang J, Yun Z, et al. (2011) Regulation of HIF-1{alpha} activity in adipose tissue by obesity-associated factors: adipogenesis, insulin, and hypoxia. Am J Physiol Endocrinol Metab 300: E877-885.
34. Ginouves A, Ilc K, Macias N, Pouyssegur J, Berra E (2008) PHDs overactivation during chronic hypoxia "desensitizes" HIFalpha and protects cells from necrosis. Proc Natl Acad Sci U S A 105: 4745-4750.
35. Li YN, Xi MM, Guo Y, Hai CX, Yang WL, et al. (2014) NADPH oxidase-mitochondria axis-derived ROS mediate arsenite-induced HIF-1alpha stabilization by inhibiting prolyl hydroxylases activity. Toxicol Lett 224: 165-174.
36. Wong BW, Kuchnio A, Bruning U, Carmeliet P (2013) Emerging novel functions of the oxygensensing prolyl hydroxylase domain enzymes. Trends Biochem Sci 38: 3-11.
37. Porporato PE, Dhup S, Dadhich RK, Copetti T, Sonveaux P (2011) Anticancer targets in the glycolytic metabolism of tumors: a comprehensive review. Frontiers in pharmacology 2: 49.
38. Aposhian HV (1989) Biochemical toxicology of arsenic. Reviews in biochemical toxicology 10: 265-299.
39. Ganapathy S, Xiao S, Yang M, Qi M, Choi DE, et al. (2014) A low-dose arsenic-induced p53 protein-mediated metabolic mechanism of radiotherapy protection. J Biol Chem 289: 5340-5347.
40. Koh MY, Powis G (2012) Passing the baton: the HIF switch. Trends Biochem Sci 37: 364-372.
41. Ward PS, Thompson CB (2012) Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell 21: 297-308.